Relapse rates with daclizumab were lower than with a standard therapy, but side effects were greater
Source: HealthDay
Related MedlinePlus Pages: Medicines, Multiple Sclerosis via MedlinePlus Health News Read More Here..
Relapse rates with daclizumab were lower than with a standard therapy, but side effects were greater
No comments:
Post a Comment